Cost of Illness, Quality of Life, and Work Outcomes in Active Ankylosing Spondylitis Patients Treated With Adalimumab in China

Objectives: To access the cost of illness, quality of life and work limitation in active ankylosing spondylitis (AS) patients using adalimumab in China. Methods: A prospective study was performed in 91 patients with active AS in China. Adult patients (aged ≥ 18 years) fulfilled the 1984 New York mod...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Public Health
Main Authors: Tu, Liudan, Xie, Ya, Liao, Zetao, Jiang, Yutong, Lv, Qing, Cao, Shuangyan, Wei, Qiujing, Gu, Jieruo
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Public Health
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7732412/
https://ncbi.nlm.nih.gov/pubmed/33330342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fpubh.2020.602334
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados